Study Design: Multicenter, prospective cohort., Objectives: Malalignment following adult spine deformity (ASD) surgery can impact outcomes and increase mechanical complications. We assess whether preoperative goals for sagittal alignment following ASD surgery are achieved., Methods: ASD patients were prospectively enrolled based on 3 criteria: deformity severity (PI-LL ≥25°, TPA ≥30°, SVA ≥15 cm, TCobb≥70° or TLCobb≥50°), procedure complexity (≥12 levels fused, 3-CO or ACR) and/or age (>65 and ≥7 levels fused). The surgeon documented sagittal alignment goals prior to surgery. Goals were compared with achieved alignment on first follow-up standing radiographs., Results: The 266 enrolled patients had a mean age of 61.0 years (SD = 14.6) and 68% were women. Mean instrumented levels was 13.6 (SD = 3.8), and 23.2% had a 3-CO. Mean (SD) offsets (achieved-goal) were: SVA = -8.5 mm (45.6 mm), PI-LL = -4.6° (14.6°), TK = 7.2° (14.7°), reflecting tendencies to undercorrect SVA and PI-LL and increase TK. Goals were achieved for SVA, PI-LL, and TK in 74.4%, 71.4%, and 68.8% of patients, respectively, and was achieved for all 3 parameters in 37.2% of patients. Three factors were independently associated with achievement of all 3 alignment goals: use of PACs/equivalent for surgical planning ( P < .001), lower baseline GCA ( P = .009), and surgery not including a 3-CO ( P = .037)., Conclusions: Surgeons failed to achieve goal alignment of each sagittal parameter in ∼25-30% of ASD patients. Goal alignment for all 3 parameters was only achieved in 37.2% of patients. Those at greatest risk were patients with more severe deformity. Advancements are needed to enable more consistent translation of preoperative alignment goals to the operating room., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: reports consultancy fees from ZimVie, NuVasive, Cerapedics, and Carlsmed; receives royalties from Zimmer Biomet and Nuvasive; holds stock in Alphatec and NuVasive; receives research funding to his institution from DePuy Synthes, International Spine Study Group Foundation (ISSGF), and AOSpine; receives fellowship grant funding to his institution from AOSpine; serves on the Executive Committee of the ISSGF; and serves on the editorial boards of Journal of Neurosurgery Spine, Neurosurgery, Operative Neurosurgery, and Spine Deformity. is a consultant for ISSGF. is a consultant for Globus Medical and Alphatec; receives royalties from NuVasive; receives research support from ISSG; receives honoraria from DePuy Synthes, Stryker, and Implanet; and has leadership roles in ISSG and the Scoliosis Research Society. is a consultant for DePuy Synthes, Stryker, and Medtronic, SI Bone, and Agnovos; receives honoraria and a fellowship grant paid to an institution from AO Spine; and has leadership roles with AOSpine. Dr. Kim receives royalties from Zimmer Biomet, Acuity Surgical, and K2M-Stryker; is a consultant for NuVasive; receives research support from the ISSGF; is on advisory boards for Vivex Biology and Aspen Medical; and has other financial or non-financial interests with AOSpine. is a consultant for Medtronic, SpineWave, Terumo, and Royal Biologics; receives honoraria from Cervical Spine Research Society, Globus Medical, and Zimmer; serves on the editorial or governing board for Spine journal; and receives research support from Allosource. receives research support from Stryker, Biom’Up, Pfizer, the Alan L. & Jacqueline B. Stuart Spine Center, National Health Foundation, Cerapedics, Empirical Spine, Inc., TSRH, and Scoliosis Research Society; receives royalties from Acuity, Medtronic, and NuVasive; is a consultant for Acuity, DePuy, Medtronic, NuVasive, FYR Medical, and Stryker; receives honoraria from Baxter, Broadwater, NASS, and Pacira Pharmaceuticals; holds patents with Medtronic; participates on a data safety monitoring board or advisory board with Medtronic; has a leadership role in the National Spine Health Foundation; owns stock/stock options in Cingulate Therapeutics and FYR Medical; is an employee of Norton Healthcare, Inc.; and serves as a journal reviewer for Global Spine Journal, Spine Deformity, and The Spine Journal. and receives research/fellowship support from NuVasive, Medtronic, SeaSpine, SI Bone, and AONA; receives royalties from SI Bone, Nuvasive, Seaspine, Aesculap, and Globus Medical; is a consultant for Aesculap, NuVasive, SI Bone, SeaSpine, Spinal Elements, Biedermann-Motech, Silony, Neo Medical, Depuy, Medtronic, Carevature, and ControlRad; has received payment/honoraria from Radius; has patents with Globus, Spine Innovation, and SI Bone; has leadership role with San Diego Spine Foundation; and has stock/stock options with Alphatec, Nuvasive, Seaspine, and SI Bone. receives grants/research support from Medtronic and Orthofix; receives royalties from Spineart and Stryker; is a consultant for Stryker Spine, Spineart, and Medtronic; and has received payment for expert testimony from multiple law firms. is a consultant for NuVasive, Viseon, Carlsmed, SI Bone, and SeaSpine; holds patents with Stryker, NuVasive, and SeaSpine; has leadership roles with Global Spine Outreach and San Diego Spine Foundation; has stock or stock options with Alphatec, SeaSpine, and NuVasive; and receives royalties from NuVasive and K2M/Stryker. is a consultant for Globus, NuVasive, and Medtronic; receives royalties from Altus; receives grants from Medtronic; and has stock or stock options from One Point Surgical. Dr. receives travel expenses to teach at the ISSG-Medtronic Spine Course for fellows and residents; and has a leadership role with the Canadian Spine Society. receives grants/research support from Prosydiuan and NuVasive. receives honoraria from Wolters Kluwer; received support for travel from AO Spine; has leadership roles with Scoliosis Research Society and AO Spine; and receives research support from the Setting Scoliosis Straight Foundation and San Diego Spine Foundation. is a consultant for Stryker Spine; receives grant/research support from Medtronic, DePuy Synthes, and AOSpine; receives honoraria from Medtronic, Stryker Spine, DePuy Synthes, Scoliosis Research Society, and AOSpine; receives support for travel from AO Spine and Scoliosis Research Society; and is on an advisory board/panel for AOSpine Research Commission and Scoliosis Research Society Research Task Force; and is Chair of the AO Spine Knowledge Forum Deformity. owns stock in J&J; is a consultant for DePuy, Medtronic, Globus; receives royalties from Innomed, DePuy, and Globus; receives honoraria from AO Spine, Wright State, and LSU; serves on the board of directors of the Scoliosis Research Society; receives travel reimbursements from DePuy, Globus, Scoliosis Research Society; and has a voluntary relationship with the National Spine Health Foundation. is a consultant for MSD, Zimmer Biomet, and Mainstay Medical; receives royalties from Zimmer Biomet, Medtronic, and Stryker; owns stock in VFT Solutions and SeaSpine; is an executive committee member of ISSG. receives royalties from DePuy Spine, Globus, and Blue Ocean Spine; is a consultant for DePuy Spine, Globus, and Blue Ocean Spine; has a leadership role in the Scoliosis Research Society and International Spine Study Group Foundation; has stock or stock options in Progenerative Medical; and has received research support from DePuy Spine and ISSGF. receives royalties from Stryker, Biomet Zimmer Spine, DePuy Synthes, NuVasive, Next Orthosurgical, K2M, and Medicrea; is a consultant for DePuy Synthes, Medtronic, Medicrea, K2M, Agada Medical, and Carlsmed; receives research support from Titan Spine, DePuy Synthes, and ISSG; serves on the editorial board of Operative Neurosurgery; receives grant funding from SRS; serves on the executive committee of ISSG; is the director of Global Spinal Analytics; and is the safety and value committee chair of SRS. is a consultant for Medtronic, ABRYX, and Acuity Surgical; receives research/grant support from AOSpine, Scoliosis Research Society, and Setting Scoliosis Straight Foundation; receives royalties from Medtronic and Acuity Surgical; and receives other financial support from Broadwater, AOSpine, and Scoliosis Research Society. is a consultant for NuVasive, SI Bone, and Proprio; owns stock in NuVasive; holds patents with NuVasive; receives fellowship funding from Globus, Medtronic, and NuVasive; and receives royalties from NuVasive, Medtronic, and SI Bone; has leadership roles with SRS and CSRS; and receives study-related clinical or research support from DePuy Synthes and ISSGF. is a consultant for Zimmer Biomet, NuVasive, Cerapedics, Carlsmed, SeaSpine, and DePuy Synthes; owns stock in Alphatec and NuVasive; receives study-related clinical or research support from DePuy Synthes and ISSGF; receives non–study-related clinical or research support from DePuy Synthes, ISSGF, and AO Spine; receives royalties from Zimmer Biomet and NuVasive; and receives fellowship support from AO Spine. is a consultant for Alphatec, Stryker, and MiRus; receives honoraria from Stryker; holds patents with Stryker; receives study-related clinical or research support from Medtronic, Globus, NuVasive, Stryker, Carlsmed, and SI Bone; receives non–study-related clinical or research support from DePuy Synthes; and receives royalties from Stryker and NuVasive. report no conflicts of interest.